Cardioprotective Effects of Electroacupuncture Pretreatment Against Coronary Stenting
Cardioprotective of Electroacupuncture Pretreatment in Patients Underwent Coronary Stenting: A Prospective, Multicenter, Randomized Control Trial
1 other identifier
interventional
500
1 country
1
Brief Summary
Myocyte necrosis as a result of elective percutaneous coronary intervention (PCI) occurs in approximately one third of cases and is associated with subsequent cardiovascular events. This study assesses the ability of electroacupuncture (EA) pretreatment to attenuate cardiac troponin I (cTnI) release after elective PCI.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2010
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 24, 2009
CompletedFirst Posted
Study publicly available on registry
November 26, 2009
CompletedStudy Start
First participant enrolled
January 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2012
CompletedDecember 16, 2011
November 1, 2011
1.9 years
November 24, 2009
December 15, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The primary outcome was assessing whether EA pretreatment before elective PCI reduced cTnI concentration at 48 hours.
48 hours after PCI
Secondary Outcomes (1)
Secondary outcomes were the effect of EA pretreatment on ischemic symptoms, ECG evidence of ischemia during coronary balloon occlusion, CRP,and major adverse cardiac events (MACE) at 6 months.
six months of PCI follow-up.
Study Arms (2)
Pretreatment
EXPERIMENTALControl
NO INTERVENTIONInterventions
According to the theory of traditional Chinese medicine, bilateral Neiguan (PC 6) acupoints were chosen and identified according to traditional anatomical localizations. Once insertion of original needles was made at the acupoints, the needle was stimulated electrically with the intensity of 2-6 mA and frequency of 2/30 Hz using the Electronic Acupuncture Treatment Instrument until the patient felt the so-called 'Teh Chi' sensation of heaviness, numbness and swelling. The pretreatment was individualized based on patients sex, age, weight and felt and given 1 time per day for 5 consecutive days before the heart valve replacement surgery.
The control patients were only placed needles at the bilateral Neiguan (PC 6)acupoints without electric stimulus.
Eligibility Criteria
You may qualify if:
- All patients \> 18 of age who are undergoing elective PCI and are able to give informed consent are eligible for study.
You may not qualify if:
- Emergency PCI,
- Elevation of cTnI before PCI taken at the preadmission clinic,
- Women of child-bearing age,
- Nicorandil or glibenclamide use (preconditioning-mimetic and preconditioning blocking medication, respectively), and
- Severe comorbidity (estimated life expectancy \< 6 months).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Xijing Hospitallead
Study Sites (1)
Xijing Hospital
Xi'an, Shaanxi, 710032, China
Related Publications (1)
Wang Q, Liang D, Wang F, Li W, Han Y, Zhang W, Xie Y, Xin W, Zhou B, Sun D, Cao F, Xiong L. Efficacy of electroacupuncture pretreatment for myocardial injury in patients undergoing percutaneous coronary intervention: A randomized clinical trial with a 2-year follow-up. Int J Cardiol. 2015 Sep 1;194:28-35. doi: 10.1016/j.ijcard.2015.05.043. Epub 2015 May 13.
PMID: 26011261DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Lize Xiong, M.D., Ph.D.
Xijing Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 24, 2009
First Posted
November 26, 2009
Study Start
January 1, 2010
Primary Completion
December 1, 2011
Study Completion
June 1, 2012
Last Updated
December 16, 2011
Record last verified: 2011-11